Position in IDYA
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$2,348,792
-$550,419 QoQ
Shares Held
70,492
-15.9% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Legal & General Group Plc holds $3,030,824,133 across 242 Biotechnology names. IDYA ranks #66 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,955,764 | $873,326,855 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
732,054 | $565,614,201 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
934,881 | $309,324,075 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,362,872 | $161,316,968 | |
| 5 | INCY |
Incyte Corp
|
1,543,188 | $145,244,853 | |
| 6 | INSM |
INSMED Inc
|
787,079 | $128,703,157 | |
| 7 | ARGX |
Argenx SE
|
150,850 | $110,158,211 | |
| 8 | MRNA |
Moderna, Inc.
|
750,841 | $38,142,721 |
All Filings in IDYA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,348,792 | 70,492 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $2,899,211 | 83,865 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $2,501,577 | 91,936 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,806,100 | 85,923 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,387,205 | 84,689 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,118,758 | 82,442 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,219,816 | 70,070 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $2,399,627 | 68,346 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $2,622,838 | 59,773 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $1,759,501 | 49,452 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $1,364,486 | 50,574 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,131,736 | 48,159 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $211,455 | 15,401 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $264,826 | 14,575 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $199,822 | 13,393 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $130,520 | 9,458 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $110,120 | 9,841 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $231,175 | 9,779 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $84,550 | 3,317 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $61,751 | 2,942 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $37,811 | 1,609 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $20,174 | 1,441 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $18,098 | 1,441 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $22,934 | 1,614 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||